The VWD2B saga continues to Montreal

Blood

Volumn 113, Issue 14, 2009, Pages 3134-3135

  Nurden, Paquita ^a  

^a French National Reference Center   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; BLEEDING; EXON; GENE MUTATION; MEGAKARYOPOIESIS; NOTE; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; VON WILLEBRAND DISEASE; VON WILLEBRAND DISEASE TYPE 2B;

EID: 65349185161     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-01-197608     Document Type: Note

References (7)

1. Ruggeri ZM. Type IIB von Willebrand disease: a paradox explains how von Willebrand factors works. J Thromb Haemost. 2004;2:2-6.
2. Jackson SC, Sinclair GD, Cloutier S, DuanX, Rand ML, Poon M-C. Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWFV1316M mutation. Blood. 2009;113:3348-3351.
3. Nurden P, Debili N, Vainchenker W, et al. Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia. Blood. 2006;108:2587-2595.
4. Slayton WB, Patel M, Sola-Visner M, et al. Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrow. J Pediatr Hematol Oncol. 2008;30:708-711.
5. Federici AB, Mannucci PM, Castaman G, et al. Clinical and molecular predictors ofthrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B:A cohort study of 67 patients. Blood. 2009;113:526-534.
6. MiltonJG,FrojmovicMM. Shape-changing agents produce abnormally large platelets in a hereditary "giant platelets syndrome (MPD)"J Lab Clin Med. 1979;93:154-161.
7. Shim K, Anderson PJ, Tuley EA, et al. Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. Blood. 2008;111:651-657.